Free Trial

What is William Blair's Forecast for Danaher Q1 Earnings?

Danaher logo with Multi-Sector Conglomerates background

Danaher Co. (NYSE:DHR - Free Report) - Research analysts at William Blair lowered their Q1 2025 earnings estimates for shares of Danaher in a research report issued to clients and investors on Monday, January 13th. William Blair analyst M. Larew now expects that the conglomerate will earn $2.00 per share for the quarter, down from their previous forecast of $2.11. The consensus estimate for Danaher's current full-year earnings is $7.50 per share. William Blair also issued estimates for Danaher's Q2 2025 earnings at $1.92 EPS, Q4 2025 earnings at $2.53 EPS and FY2025 earnings at $8.37 EPS.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business's quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.02 earnings per share.

A number of other research firms have also issued reports on DHR. Robert W. Baird lowered their target price on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 23rd. Guggenheim assumed coverage on Danaher in a research report on Thursday, December 19th. They issued a "buy" rating and a $275.00 price target on the stock. StockNews.com cut Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. Bank of America raised Danaher from a "neutral" rating to a "buy" rating and set a $290.00 target price on the stock in a report on Friday, December 13th. Finally, Barclays reduced their price objective on Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $286.80.

Read Our Latest Analysis on Danaher

Danaher Stock Down 1.0 %

Shares of Danaher stock opened at $237.58 on Wednesday. The stock has a 50 day moving average price of $235.27 and a two-hundred day moving average price of $253.56. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher has a 12-month low of $222.53 and a 12-month high of $281.70. The stock has a market capitalization of $171.60 billion, a P/E ratio of 45.34, a PEG ratio of 4.32 and a beta of 0.83.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher's payout ratio is presently 20.61%.

Hedge Funds Weigh In On Danaher

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. FMR LLC boosted its stake in Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares in the last quarter. Legal & General Group Plc boosted its stake in shares of Danaher by 2.4% in the 2nd quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock valued at $1,490,112,000 after purchasing an additional 139,989 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Danaher by 3.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate's stock worth $1,417,342,000 after acquiring an additional 148,251 shares during the period. Fisher Asset Management LLC grew its stake in shares of Danaher by 2.6% during the third quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock worth $1,265,725,000 after purchasing an additional 116,299 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its position in shares of Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock worth $996,141,000 after buying an additional 535,254 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Company Profile

(Get Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Earnings History and Estimates for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Affordable AI Stocks: 7 Picks Under $50
2025 Natural Gas Comeback: 3 Stocks Poised for Big Gains
Why the Latest Jobs Data Has Wall Street Nervous

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines